Google
 
Web www.vitaminlore.com
www.eniva.com

Sucralfate

Also indexed as: Carafate®

Sucralfate is used to treat intestinal ulcers, and it is a type of drug known as a polysaccharide antipeptic.

Interactions with Dietary Supplements

Calcium
Slight increases in blood calcium levels may occur in people taking sucralfate, which could be aggravated by calcium supplementation.1 Therefore, people taking calcium supplements and sucralfate should have their blood calcium levels monitored by their healthcare practitioner and may need to avoid calcium supplementation.

Phosphorus
People taking sucralfate may develop lower than normal blood levels of phosphorus.2 A 42-year-old woman who took sucralfate for two weeks experienced bone pain that was caused by low phosphorus levels. The bone pain disappeared after she stopped taking the drug and began supplementing with phosphorus.3 Individuals taking sucralfate should have their blood phosphorus levels monitored regularly by their healthcare practitioner and may need to take supplemental phosphorus.

Summary of Interactions for Sucralfate

Depletion or interference Calcium
Phosphorus
Adverse interaction None known
Side effect reduction/prevention None known
Supportive interaction None known
Reduced drug absorption/bioavailability None known

For the convenience of the reader, the information in the summary is categorized as follows: “Depletion or interference” indicates the drug may deplete or interfere with the absorption or function of the supplement or herb. “Adverse interaction” indicates that the supplement or herb used together with the drug may result in undesirable effects. “Side effect reduction/prevention” indicates the supplement or herb may reduce the likelihood and/or severity of a potential side effect caused by the drug. “Supportive interaction” indicates the supplement or herb may support or aid the function of the drug. “Reduced drug absorption/bioavailability” indicates that the supplement or herb may decrease the absorption and/or activity of the drug in the body. An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

References:

1. Vucelic B, Hadzic N, Gragas J, Puretic Z. Changes in serum phosphorus, calcium, and alkaline phosphatase due to sucralfate. Int J Clin Pharmacol Ther Toxicol 1986;24:93–6.

2. Vucelic B, Hadzic N, Gragas J, Puretic Z. Changes in serum phosphorus, calcium, and alkaline phosphatase due to sucralfate. Int J Clin Pharmacol Ther Toxicol 1986;24:93–6.

3. Chines A, Pacifici R. Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature. Calcif Tissue Int 1990;47:291–5.